Outpatient Medical Injectable Monoclonal Antibodies for the Treatment of Asthma and Eosinophilic Conditions Request Form
Customize your policy alerts
Sign up for all Highmark Pennsylvania policy alerts
Know when Highmark Pennsylvania releases new policies or updates existing guidance.
Monitor payer policy activity
Request form and documentation requirements for outpatient medical benefit coverage of monoclonal antibody injectables (e.g., Fasenra, Nucala, Cinqair, Tezspire) for asthma and eosinophilic conditions; intended for ordering providers and facility staff to request prior authorization or medical review.
No material clinical or coverage changes in this revision.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.